{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:11:43Z","timestamp":1792069903090,"version":"4.4.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1097\/olq.0b013e318224db39","type":"journal-article","created":{"date-parts":[[2011,6,16]],"date-time":"2011-06-16T17:06:19Z","timestamp":1308243979000},"page":"983-987","source":"Crossref","is-referenced-by-count":57,"title":["Utility of Antimicrobial Susceptibility Testing in Trichomonas vaginalis\u2013Infected Women With Clinical Treatment Failure"],"prefix":"10.1097","volume":"38","author":[{"given":"Elizabeth A.","family":"Bosserman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna J.","family":"Helms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra J.","family":"Mosure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Evan","family":"Secor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Workowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210213","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1363\/3600604","article-title":"Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000.","volume":"6","author":"Weinstock","year":"2004","journal-title":"Perspect Sex Reprod Health"},{"key":"R2-21-20210213","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/00007435-199904001-00002","article-title":"Estimates of the incidence and prevalence of sexually transmitted diseases in the United States.","volume":"6","author":"Cates","year":"1999","journal-title":"Sex Transm Dis"},{"key":"R3-21-20210213","first-page":"771","article-title":"Sexually Transmitted Disease, 4th ed.","author":"Hobbs","year":"2008"},{"key":"R4-21-20210213","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1086\/522532","article-title":"The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001\u20132004.","volume":"5","author":"Sutton","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R5-21-20210213","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/09674845.2005.11732710","article-title":"Trichomonas vaginalis: Paradigm of a successful sexually transmitted organism.","volume":"2","author":"Rughooputh","year":"2005","journal-title":"Br J Biomed Sci"},{"issue":"RR-12","key":"R6-21-20210213","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines.","volume":"9","year":"2010","journal-title":"MMWR"},{"key":"R7-21-20210213","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1086\/511278","article-title":"Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition.","volume":"95","author":"McClelland","year":"2007","journal-title":"J Infect Dis"},{"key":"R8-21-20210213","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00007435-199707000-00008","article-title":"Trichomonas vaginalis associated with low birth weight and preterm delivery.","volume":"4","author":"Cotch","year":"1997","journal-title":"Sex Transm Dis"},{"key":"R9-21-20210213","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0889-8545(21)00370-3","article-title":"Metronidazole.","volume":"9","author":"Hager","year":"1992","journal-title":"Obstet Gynecol North Am"},{"key":"R10-21-20210213","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00003088-199936050-00004","article-title":"Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.","volume":"6","author":"Lamp","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"R11-21-20210213","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/AAC.47.4.1407-1409.2003","article-title":"In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis.","volume":"7","author":"Crowell","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"R12-21-20210213","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199907223410417","article-title":"Metronidazole-resistant vaginal trichomoniasis\u2013an emerging problem.","volume":"41","author":"Sobel","year":"1999","journal-title":"N Engl J Med"},{"key":"R13-21-20210213","first-page":"CD000218","article-title":"Interventions for treating trichomoniasis in women.","author":"Forna","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"R14-21-20210213","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2165\/00003495-197611060-00003","article-title":"Tinidazole: A review of its antiprotozoal activity and therapeutic efficacy.","volume":"1","author":"Sawyer","year":"1976","journal-title":"Drugs"},{"key":"R15-21-20210213","first-page":"665","article-title":"Trichomonal vaginitis resistant to metronidazole.","volume":"6","author":"Robinson","year":"1962","journal-title":"Med Assoc J"},{"key":"R16-21-20210213","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1128\/AAC.00814-06","article-title":"Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole.","volume":"0","author":"Schwebke","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"R17-21-20210213","first-page":"545","article-title":"Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic.","volume":"6","author":"Schmid","year":"2001","journal-title":"J Reprod Med"},{"issue":"suppl 3","key":"R19-21-20210213","first-page":"S58","article-title":"The efficacy of povidone-iodine pessaries in a short, low-dose treatment regime on candidal, trichomonal and non-specific vaginitis.","volume":"9","author":"Yu","year":"1993","journal-title":"Postgrad Med J"},{"key":"R20-21-20210213","first-page":"213","article-title":"Metronidazole treatment of vaginal trichomoniasis. II: Oral versus vaginal therapy.","volume":"9","author":"Porapakkham","year":"1967","journal-title":"Obstet Gynecol"},{"key":"R21-21-20210213","doi-asserted-by":"crossref","first-page":"370E1","DOI":"10.1016\/j.ajog.2007.10.795","article-title":"Management of Trichomonas vaginalis in women with suspected metronidazole hypersensitivity.","volume":"98","author":"Helms","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R22-21-20210213","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1086\/513951","article-title":"Difficult-to-treat trichomoniasis: Results with paromomycin cream.","volume":"6","author":"Nyirjesy","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R23-21-20210213","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1258\/0956462054308422","article-title":"Management of metronidazole-resistant Trichomonas vaginalis: A new approach.","volume":"6","author":"Mammen-Tobin","year":"2005","journal-title":"Int J STD AIDS"},{"key":"R24-21-20210213","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1086\/323034","article-title":"Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.","volume":"3","author":"Sobel","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R27-21-20210213","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1128\/JCM.28.5.962-964.1990","article-title":"Growth of Trichomonas vaginalis in commercial culture media.","volume":"8","author":"Gelbart","year":"1990","journal-title":"J Clin Microbiol"},{"key":"R28-21-20210213","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1128\/AAC.15.2.254","article-title":"Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles.","volume":"5","author":"Meingassner","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"R29-21-20210213","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/infdis\/153.5.948","article-title":"In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis.","volume":"53","author":"Lossick","year":"1986","journal-title":"J Infect Dis"}],"container-title":["Sexually Transmitted Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007435-201110000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:34:28Z","timestamp":1786044868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007435-201110000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/olq.0b013e318224db39","relation":{},"ISSN":["0148-5717"],"issn-type":[{"value":"0148-5717","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}